ReddyS, HuiD, El OstaB, de la CruzM, WalkerP, PalmerJL, BrueraE. The effect of oral methadone on the QTc interval in advanced cancer patients: A prospective pilot study. J Palliat Med, 2010; 13:33–38.
2.
HarrisRI, SteareSE. A meta-analysis of ECG data from healthy male volunteers: Diurnal and intrasubject variability and planning for ECG assessments and statistical analysis in clinical pharmacology studies. Eur J Clin Pharm, 2006; 62:893–903.
3.
LewisMJ, RassiD, ShortAL. Analysis of the QT interval and its variability in healthy adults during rest and exercise. Physiol Meas, 2006; 27:1211–1226.
4.
HolbrookM, MalikM, ShahRR, ValentinJP. Drug induced shortening of the QT/QTc interval: An emerging safety issue warranting further modeling and evaluation in drug research and development?J Pharmacol Toxicol Methods, 2009; 59,1:21–28.
5.
KatchmanAN, McGroaryKA, KilbornMJ, KornickCA, ManfrediPL, EbertSN, WoosleyRL. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther, 2002; 303:688–694.
6.
WedamEF, BigelowGE, JohnsonRE, NuzzoPA, HaigneyCP. QT interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med, 2007; 22:2469–2476.
